|
1
|
Cui R, Kamatani Y, Takahashi A, Usami M,
Hosono N, Kawaguchi T, Tsunoda T, Kamatani N, Kubo M, Nakamura Y
and Matsuda K: Functional variants in ADH1B and ALDH2 coupled with
alchol and smoking synergistically enhance esophageal cancer risk.
Gastroenterology. 137:1768–1775. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yokoyama T, Yokoyama A, Kato H, Tsujinaka
T, Muto M, Omori T, Haneda T, Kumagai Y, Igaki H, Yokoyama M, et
al: Alcohol flushing, alcohol and aldehyde dehydrogenase genotypes,
and risk for esophageal squamous cell carcinoma in Japanese men.
Cancer Epidemiol Biomarkers Prev. 12:1227–1233. 2003.PubMed/NCBI
|
|
3
|
Mitsumori T, Matsusaka T, Wakasugi K,
Takenaka M, Kume K, Fujinaga Y, Teraoka H and Iwashita A: A
clinicopathological study of gastric cancer with special reference
to age of the patients: An analysis of 1,630 cases. World J Surg.
13:225–230; discussion 230–231. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Japanese Society of Esophageal Diseases:
Comprehensive registry of esophageal cancer in Japan, 1999.
Esophagus. 2:43–69. 2005. View Article : Google Scholar
|
|
5
|
Ohtsu A: Chemoradiotherapy for esophageal
cancer: Current status and perspectives. Int J Clin Oncol.
9:444–450. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ajani J, Bekaii-Saab T, D'Amico TA, Fuchs
C, Gibson MK, Goldberg M, Hayman JA, Ilson DH, Javle M, Kelley S,
et al: Esophageal Cancer Clinical Practice Guidelines. J Natl Compr
Canc Netw. 4:328–347. 2006.PubMed/NCBI
|
|
7
|
Ishihara R, Yamamoto S, Lishi H, Takeuchi
Y, Sugimoto N, Higashino K, Uedo N, Tatsuta M, Yano M, Imai A and
Nishiyama K: Factors predictive of tumor recurrence and survival
after initial complete response of esophageal squamous cell
carcinoma to definitive chemoradiotherapy. Int J Radiat Oncol Biol
Phys. 76:123–129. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kato K, Muto K, Minashi K, Ohtsu A,
Ishikura S, Boku N, Takiuchi H, Komatsu Y, Miyata Y and Fukuda H:
Gastrointestinal Oncology Study Group of the Japan Clinical
Oncology Group (JCOG): Phase II study of chemoradiotherapy with
5-fluorouracil and cisplatin for stage II–III esophageal squamous
cell carcinoma: JCOG trial (JCOG 9906). Int Radiat Oncol Biol Phys.
81:684–690. 2011. View Article : Google Scholar
|
|
9
|
Suzuki A, Xiao L, Hayashi Y, Blum MA,
Welsh JW, Lin SH, Lee JH, Bhutani MS, Weston B, Maru DM, et al:
Nomograms for prognostication of outcome in patients with
esophageal and gastroesophageal carcinoma undergoing definitive
chemoradiotherapy. Oncology. 82:108–113. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yano T, Muto M, Hattori S, Minashi K,
Onozawa M, Nihei K, Ishikura S, Ohtsu A and Yoshida S: Long-term
results of salvage endoscopic mucosal resection in patients with
local failure after definitive chemoradiotherapy for esophageal
squamous cell carcinoma. Endoscopy. 40:717–721. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Oyama T: Counter traction makes endoscopic
submucosal dissection easier. Clin Endosc. 45:375–378. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Edge SB, Byrd DR, Compton CC, Fritz AG and
Greene FL: AJCC Cancer Staging Manual (7th). Springer-Verlag. New
York, NY: 2010.
|
|
13
|
Kato H and Nakajima M: Treatments for
esophageal cancer: A review. Gen Thorac Cardiovasc Surg.
61:330–335. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Michel P, Adenis A, Di Fiore F, Boucher E,
Galais MP, Dahan L, Mirabel X, Hamidou H, Raoul JL, Jacob JH, et
al: Induction cisplatin-irinotecan followed by concurrent
cisplatin-irrinotecan and radiotherapy without surgery in
oesophageal cancer: Multicenter phase II FFCD trial. Br J Cancer.
95:705–709. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Conroy T, Yataghène Y, Etienne PL, Michel
P, Senellart H, Raoul JL, Mineur L, Rives M, Mirabel X, Lamezec B,
et al: Phase II randomised trial of chemoradiotherapy with FOLFOX4
or cisplatin plus fluorouracil in oesophageal cancer. Br J Cancer.
103:1349–1355. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Minsky BD, Pajak TF, Ginsberg RJ, Pisansky
TM, Martenson J, Komaki R, Okawara G, Rosenthal SA and Kelsen DP:
INT 0123 (Radiation Therapy Oncology Group 94-05) Phase III trial
of combined-modality therapy for esophageal cancer: High-dose
versus standard-dose radiation therapy. J Clin Oncol. 20:1167–1174.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Crosby TD, Brewster AE, Borley A, Perschky
L, Kehagioglou P, Court J and Maughan TS: Definitive chemoradiation
in patients with inoperable oesophageal carcinoma. Br J Cancer.
90:70–75. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Welsh J, Settle SH, Amini A, Xiao L,
Suzuki A, Hayashi Y, Hofstetter W, Komaki R, Liao Z and Ajani JA:
Failure patterns in patients with esophageal cancer treated with
definite chemoradiation. Cancer. 118:2632–2640. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kudou M, Shiozaki A, Fujiwara H, Kosuga T,
Konishi H, Morimura R, Murayama Y, Komatsu S, Kuriu Y, Ikoma H, et
al: Clinical analysis of esophageal cancer patients with a history
of metachronous primary cancer. Gan To Kagaku Ryoho. 41:2030–2032.
2014.PubMed/NCBI
|
|
20
|
Swisher SG, Wynn P, Putnam JB, Mosheim MB,
Correa AM, Komaki RR, Ajani JA, Smythe WR, Vaporciyan AA, Roth JA
and Walsh GL: Salvage esophagectomy for recurrent tumors after
definitive chemotherapy and radiotherapy. J Thorac Cardiovasc Surg.
123:175–183. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Meunier B, Raoul J, Le Prisé E, Lakéhal M
and Launois B: Salvage esophagectomy agter unsuccessful curative
chemoradiotherapy for squamous cell cancer of the esophagus. Dig
Surg. 15:224–226. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nakamura T, Hayashi K, Ota M, Eguchi R,
Ide H, Takasaki K and Mitsuhashi N: Salvage esophagectomy after
definitive chemotherapy and radiotherapy for advanced esophageal
cancer. Am J Surg. 188:261–266. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Amimi A, Ajani J, Komaki R, Allen PK,
Minsky BD, Blum M, Xiao L, Suzuki A, Hofstetter W, Swisher S, et
al: Factors associated with local-regional failure after definitive
chemoradiation for locally advanced esophageal cancer. Ann Surg
Oncol. 21:306–314. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Juloori A, Tucker SL, Komaki R, Liao Z,
Correa AM, Swisher SG, Hofstetter WL and Lin SH: Influence of
preoperative radiation field on postoperative leak rates in
esophageal cancer patients after trimodality therapy. J Thorac
Oncol. 9:534–540. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gardner-Thorpe J, Hadwick RH and
Dwerryhous SJ: Salvage esophagectomy after local failure of
definitive chemoradiotherapy. Br J Surg. 94:1059–1066. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
D'Journo XB, Michelet P, Dahan L, Doddoli
C, Seitz JF, Giudicelli R, Fuentes PA and Thomas PA: Indications
and outcome of salvage surgery for esophageal cancer. Eur J
Cardiothrorac Surg. 33:1117–1123. 2008. View Article : Google Scholar
|
|
27
|
Yano T, Muto M, Minashi K, Onozawa M,
Nihei K, Ishikura S, Kaneko K and Ohtsu A: Long-term results of
salvage photodynamic therapy for patients with local failure after
chemoradiotherapy for esophageal squamous cell carcinoma.
Endoscopy. 43:657–663. 2011. View Article : Google Scholar : PubMed/NCBI
|
